NEW YORK (GenomeWeb News) — The National Cancer Institute has renewed the Moores Cancer Center’s status as a Comprehensive Cancer Center and has funded it with $21 million over five years, the University of California at San Diego said this week.
 
UCSD said it will use the grant to fund research costs and operational expenses for its 10 core facilities, which include labs and hardware for DNA sequencing, microarraying, bioinformatics, clinical trials, and other genomics, imaging, and cancer-related development endeavors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.